经阴道超声联合血清sB7-H4、YKL-40、SDF-1对卵巢恶性肿瘤的诊断价值OA
Diagnostic value of transvaginal ultrasound combined with serum sB7-H4,YKL-40 and SDF-1 for ovarian malignant tumors
目的 探讨经阴道超声联合血清可溶性B7-H4(sB7-H4)、人软骨糖蛋白-39(YKL-40)、基质细胞衍生因子-1(SDF-1)对卵巢恶性肿瘤的诊断价值.方法 选取2022年3月至2024年3月在该院接受手术治疗且术后病理组织学检查确诊的148例卵巢肿瘤患者作为研究对象,根据病理检查结果,将其分为恶性组(57例)和良性组(91例).检测并对比2组血清sB7-H4、YKL-40、SDF-1水平;使用彩色多普勒超声观察病灶内血流情况,并记录血管搏动指数(PI)、阻力指数(RI).绘制受试者工作特征(ROC)曲线分析血清sB7-H4、YKL-40、SDF-1对卵巢恶性肿瘤的诊断价值;采用四格表法分析经阴道超声联合血清sB7-H4、YKL-40、SDF-1对卵巢恶性肿瘤的诊断效能,采用串联方式进行4项联合分析.结果 与良性组相比,恶性组患者肿瘤的形态模糊、回声不规则、无包膜占比及血清sB7-H4、YKL-40、SDF-1水平明显升高(P<0.05),PI、RI明显降低(P<0.05).经阴道超声联合血清sB7-H4、YKL-40、SDF-1对卵巢恶性肿瘤的诊断结果与金标准具有一致性(Kappa=0.773,P<0.001),经阴道超声及血清sB7-H4、YKL-40、SDF-1单独诊断结果分别与金标准具有一致性(Kappa=0.627、0.704、0.684、0.662,均P<0.001).ROC曲线分析结果显示,血清sB7-H4、YKL-40、SDF-1单独诊断卵巢恶性肿瘤的曲线下面积分别为0.889、0.881、0.883,最佳截断值分别为78.15 μg/L、60.34 pg/mL、5.66 μg/L.经阴道超声联合血清sB7-H4、YKL-40、SDF-1诊断卵巢恶性肿瘤的灵敏度为80.70%,特异度为96.70%,准确度为90.54%.4项联合诊断卵巢恶性肿瘤的灵敏度明显低于经阴道超声单独诊断(P<0.05),特异度明显高于经阴道超声及血清sB7-H4、YKL-40、SDF-1单独诊断(P<0.05),准确度明显高于经阴道超声单独诊断(P<0.05).结论 卵巢恶性肿瘤患者血清sB7-H4、YKL-40、SDF-1水平均明显上调,经阴道超声联合血清sB7-H4、YKL-40、SDF-1可有效提高诊断卵巢恶性肿瘤的准确度,为临床制订合理的治疗方案提供一定参考.
Objective To explore the diagnostic value of transvaginal ultrasound combined with serum sol-uble B7-4(sB7-H4),human cartilage glycoprotein-39(YKL-40)and stromal cell-derived factor-1(SDF-1)for ovarian malignant tumors.Methods A total of 148 patients with ovarian tumors who underwent surgical treatment in the hospital from March 2022 to March 2024 were selected as the research subjects,who were di-vided into malignant group(n=57)and benign group(n=91)according to the results of pathological exami-nation.The serum levels of sB7-H4,YKL-40 and SDF-1 in the two groups were detected and compared.Color Doppler ultrasound was used to observe the blood flow in the lesions,and the pulsatility index(PI)and resist-ance index(RI)were recorded.The receiver operating characteristic(ROC)curve was drawn to analyze the diagnostic value of serum sB7-H4,YKL-40 and SDF-1 for ovarian malignant tumors.The four-fold table method was used to analyze the diagnostic efficiency of transvaginal ultrasound combined with serum sB7-H4,YKL-40 and SDF-1 for ovarian malignant tumors,and the four items were analyzed in combination in series.Results Compared with the benign group,the proportions of blurred tumor morphology,irregular echo and no capsule,and the serum levels of sB7-H4,YKL-40 and SDF-1 in the malignant group were significantly in-creased(P<0.05),while PI and RI were significantly decreased(P<0.05).The diagnostic results of trans-vaginal ultrasound combined with serum sB7-H4,YKL-40 and SDF-1 for ovarian malignant tumors were con-sistent with the gold standard(Kappa=0.773,P<0.001).The diagnostic results of transvaginal ultrasound,serum sB7-H4,YKL-40 and SDF-1 alone were also consistent with the gold standard respectively(Kappa=0.627,0.704,0.684,0.662,all P<0.001).The results of ROC curve analysis showed that the areas under the curve(AUCs)of serum sB7-H4,YKL-40 and SDF-1 in diagnosing ovarian malignant tumors were 0.889,0.881 and 0.883 respectively,and the optimal cut-off values were 78.15 μg/L,60.34 pg/mL and 5.66 μg/L respectively.The sensitivity,specificity and accuracy of transvaginal ultrasound combined with serum sB7-H4,YKL-40 and SDF-1 in diagnosing ovarian malignant tumors were 80.70%,96.70%and 90.54%respectively.The sensitivity of the four-combined diagnosis of ovarian malignant tumors was significantly lower than that of transvaginal ultrasound alone(P<0.05),the specificity was significantly higher than that of transvaginal ultrasound,serum sB7-H4,YKL-40 and SDF-1 alone(P<0.05),and the accuracy was significantly higher than that of transvaginal ultrasound alone(P<0.05).Conclusion The serum levels of sB7-H4,YKL-40 and SDF-1 in patients with ovarian malignant tumors are significantly up-regulated,and transvaginal ultrasound combined with serum sB7-H4,YKL-40 and SDF-1 can effectively improve the accuracy of diagnosing ovarian malignant tumors,providing certain reference for clinical formulation of reasonable treatment plans.
曹晨;曹阳;邓莉华
湖北省监利市人民医院妇科,湖北 荆州 433300湖北省监利市人民医院妇科,湖北 荆州 433300湖北省监利市人民医院妇科,湖北 荆州 433300
医药卫生
卵巢恶性肿瘤经阴道超声可溶性B7-H4人软骨糖蛋白-39基质细胞衍生因子-1
ovarian malignant tumortransvaginal ultrasoundsoluble B7-H4human cartilage gly-coprotein-39stromal cell-derived factor-1
《检验医学与临床》 2026 (8)
1124-1129,6
评论